MedAmicus gets 510(k) for LuMax applications:
This article was originally published in Clinica
MedAmicus has received US FDA clearance to market the urinary flow and pressure/flow capabilities of its LuMax fibre-optic cystometry system. The system is currently marketed for obstetric and gynaecological applications. Urology sales will commence in May, says marketing manager Jennifer Peters.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.